ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,994Medicare Part D Prescriptions Filled, Including Refills

Rank: 245 out of 1454

$639K Total Retail Price of All Prescriptions

Rank: 278 out of 1454

386 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,457 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 677 637 1 3
WARFARIN SODIUM 653 650 2 17
FUROSEMIDE 612 591 3 6
CITALOPRAM HBR 471 471 4 21
LEVOTHYROXINE SODIUM 357 334 5 5
LISINOPRIL 260 242 6 4
METOPROLOL TARTRATE 254 250 7 10
POTASSIUM CHLORIDE 242 217 8 15
NAMENDA 236 236 9 48
SIMVASTATIN 228 227 10 1
DONEPEZIL HCL 201 201 11 29
QUETIAPINE FUMARATE 186 167 12 91
POLYETHYLENE GLYCOL 3350 176 172 13 61
GABAPENTIN 173 163 14 16
AMLODIPINE BESYLATE 166 164 15 2
ISOSORBIDE MONONITRATE ER 164 163 16 46
OXYCODONE HCL 160 130 S2 17 80
MIRTAZAPINE 149 149 18 53
METOPROLOL SUCCINATE 149 136 18 13
ATORVASTATIN CALCIUM 147 142 20 11
METFORMIN HCL 145 139 21 8
NOVOLIN R 142 140 22 180
IPRATROPIUM-ALBUTEROL 133 133 23 151
TRAMADOL HCL 131 130 24 20
PANTOPRAZOLE SODIUM 127 125 25 31
DIOVAN 122 122 26 40
CLOPIDOGREL 122 121 26 32
DIGOXIN 112 110 28 70
LANTUS 112 108 28 51
TAMSULOSIN HCL 110 99 30 34
LEVOFLOXACIN 104 96 31 95
PREDNISONE 100 91 32 36
CYMBALTA 91 91 33 55
CARVEDILOL 88 88 34 24
HYDROCODONE-ACETAMINOPHEN 87 84 S3 35 7
PRAVASTATIN SODIUM 78 77 36 12
SERTRALINE HCL 76 75 37 26
FLOVENT HFA 76 76 37 276
OXYCONTIN 75 74 S2 39 173
NYSTOP 75 75 39 245
PLAVIX 74 74 41 45
AZITHROMYCIN 72 68 42 42
KLOR-CON M20 68 64 43 54
CEPHALEXIN 68 68 43 127
FENTANYL 68 68 S2 43 104
ALLOPURINOL 66 66 46 28
ROPINIROLE HCL 65 65 47 96
DIVALPROEX SODIUM 63 44 48 106
HYDRALAZINE HCL 61 60 49 67
DILTIAZEM 24HR CD 59 55 50 76
FLUTICASONE PROPIONATE 59 53 50 30
ADVAIR DISKUS 56 46 52 47
CIPROFLOXACIN HCL 56 52 52 64
ESCITALOPRAM OXALATE 55 46 54 78
CEFTRIAXONE 55 55 54 213
CARBIDOPA-LEVODOPA 50 50 56 130
SEROQUEL 50 50 56 177
GLIPIZIDE 50 50 56 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.